NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
Back to search
Official data from USPTO
TISENTO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TISENTO THERAPEUTICS
ST13
US500000098075658Class
5, 42
Filing
98075658
Registration
8232876
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/28/2026
Trademark type
Word
Nice classes
5, 42
Filing date
07/07/2023
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/28/2025
First use in commerce
07/28/2025
Drawing code
4
Owner type
03
Owner location
CAMBRIDGE, MA, US
Examiner
GRAJEDA, HECTOR M
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TISENTO THERAPEUTICS INC.
JW Cycle Inc.
Representatives
Anessa Kramer Honigman LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of mitochondrial diseases or disorders
Class 42
Pharmaceutical research and development; conducting pharmaceutical clinical trials for others in the field of mitochondrial disease; pharmaceutical product development
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/09/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/09/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/08/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/07/2026
IUAF
USE AMENDMENT FILED
10/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/17/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX1G
SOU EXTENSION 1 GRANTED
06/10/2025
EXT1
SOU EXTENSION 1 FILED
06/10/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/10/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/26/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/26/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/29/2024
GNRT
NON-FINAL ACTION E-MAILED
03/29/2024
CNRT
NON-FINAL ACTION WRITTEN
03/29/2024
DOCK
ASSIGNED TO EXAMINER
03/18/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2023
NWAP
NEW APPLICATION ENTERED
07/11/2023
Continuous trademark protection
Get notified about every new filing that threatens TISENTO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.